Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2018-08-10 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于公司控股股东股份质押公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the company's controlling shareholder. It details the number of shares pledged, the pledge period, the pledgee, and the impact on shareholding and control. There are no financial statements, earnings data, or management discussion. The document is short (1160 characters) and serves as a disclosure of a financing-related event involving share pledges. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising or capital structure changes such as share pledges.
2018-08-10 Chinese
关于公司实际控制人股份质押延期购回的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the extension of the repurchase period for pledged shares held by the actual controller of the company. It details the number of shares pledged, the original and extended pledge expiration dates, and the proportion of shares pledged. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledge and repurchase extension, which fits best under the category of Regulatory Filings (RNS) as it does not match other more specific categories like Share Issue/Capital Change or Director's Dealing. The document length is short and it is an announcement rather than a report or detailed filing.
2018-07-11 Chinese
关于公司实际控制人部分股份解除质押公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by the company's actual controller, including details about the number of shares released from pledge, dates, and percentages of total shares. It does not contain financial statements, audit information, or management discussion. It is a regulatory announcement about share pledge status, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like shareholding notifications (MRQ) which typically involve changes in ownership thresholds, or share issue announcements (SHA). The document length is short and it is an announcement rather than a report or filing of financial data.
2018-06-19 Chinese
关于公司控股股东股份质押公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the company's controlling shareholder. It details the number of shares pledged, the pledge period, the pledgee, and the impact on control. There is no financial report, earnings data, or management discussion. The document is short (1133 characters) and serves as a regulatory disclosure about share pledging activity. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like share issue or director dealings.
2018-06-14 Chinese
关于参加投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an online investor collective reception day event. It mentions interaction with investors, including Q&A with company executives, but does not contain any financial statements, detailed financial data, or report content. The document is short (781 characters) and serves as a notice of an event rather than a report or detailed presentation. It does not fit categories like Annual Report, Earnings Release, or Investor Presentation. It is an announcement related to investor relations activities, which aligns best with Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2018-06-06 Chinese
第三届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by the company 葵花药业集团股份有限公司. It details the approval of a transaction involving the acquisition of a 70% stake in another company. The document includes voting results and references the board meeting date and notification process. There is no financial report, audit, or earnings data presented. The content focuses on board decisions and management actions, specifically a corporate acquisition approval. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2018-06-04 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.